OSAKA -- Three academic and business groups in Japan are planning to conduct clinical studies on donated stem cells in the fiscal year starting next month, aiming to commercialize such regenerative therapy.
So far, only one clinical study has looked at creating tissue from induced pluripotent stem cells. The cells could be harvested from donors and grown into skin and other body parts that would replace damaged tissue.
